chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever and all over body aches, moderate back pain x 24 hours. Had to leave work early. V-safe app asked if i had 2nd injection. Said yes, but it never came back to ask if i had symptoms with 2nd injection.  My vaccine was moderna.
Swollen lymph nodes on my clavicle; A spontaneous report (United States) was received from a nurse concerning a 44-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and had swollen lymph nodes on clavicle.  The patient's medical history was not reported by the reporter. Concomitant medications were not provided.  On 31 Dec 2020, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) through intramuscular route at right deltoid for prophylaxis of COVID-19 infection.  On 08 Jan 2021, the patient noticed that she had a swollen bump on her clavicle, on the same side as her injection. She had a CT scan on 08 Jan 2021 to determine that her lymph nodes were swollen. She has had no treatment at that time.  Treatment for event was reported as none.  Action taken with mRNA-1273 in response to the event was unknown.   The outcome of event, swollen lymph nodes on clavicle was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
8/30/21  SEEN IN ER WITH FEVER, CHILLS INCREASEING COUGHING AND DIFFICULTY BREATHING. . REPORTED NAUSE VOMINITING DIARRHEA. ADMITTED TO HOSPITAL. WIHT DX OF BILAT. PNEUMONIA. REQUIRED OXYGEN.   9/2/21 PATIENT DISCHARGED FROM HOSPITAL TO HOME.
This spontaneous report as received from a healthcare worker (office manager) via a company representative refers to an 8 years and 10 months old male patient. On an unknown date, the 8 years and 10 months old patient was vaccinated with a first dose of GARDASIL (exact dose, route, lot# and expiration date were not reported). No adverse effects were reported. No PQC (product quality complaint) was reported. Additional information has been requested.
Information has been received from a special education teacher, concerning a male student between 6 to 7 years old, who on an unspecified date received a dose of MMR II (Lot number not available) and on an unspecified date was hospitalized (Hospital demographics not available) after he received MMR II. The teacher reported that the student was now in special education school (no further details available). At the time of reporting, the patient was not recovered. This is one of several reports from the same source. This is an amended report. Labeling was changed from Yes to No for the AE term of Adverse Event. Additional information is not expected.
MOMENTS AFTER VACCINE GIVEN, FELT LIGHTHEADED, BROUGHT BACK VIA W.C. BY STAFF AND ASSISTED TO STRETCHER. PLACED IN TRENDELENBERG, STATES FEELING BETTER. THEN HOB RAISED AND SNACK/WATER/JUICE GIVEN. STATES DID NOT EAT ENOUGH TODAY, FEELING MUCH BETTER AFTER SNACK. SAT AT SIDE OF BED AND STATES S/S RESOLVED. CALLED MOTHER TO MEET AT APPROPRIATE EXIT, ESCORTED OUTSIDE WITH NO ISSUES AT 1450. 1420 INITIAL BP 148/91 HR 88 RR 21 SATS 99% ON RA 1430 BP 152/88 HR 90 RR 22 SATS 99% ON RA
My neck pain and back pain worsen, having strong headaches, feel sometime desoriented like getting confuse where I'm going to put something, example fill a glass of water and instead of put the container in fridge I 'm going to put the glass of water instead. In my left foot I feel cramps that I never felt before.
This writer was informed by the clinical site lead RN, that the covering physician approved an first booster Novavax for the patient. This writer noted that it has not been 6 months since the patient last dose. This writer informed clinical site lead RN of this, Clinical site lead RN, informed this writer, that he verified with the covering physician, it was okay to vaccinate the patient. This writer repeated himself and verified that the covering physician approved the Novavax booster for the patient on 11/8/2022 even though it's has not been 6 months. Per clinical site lead RN, This writer received the okay to vaccinate patient with the Novavax booster with the covering physician approval even though it has not been 6 months.
Initial report received from a health care professional in 04 Mar 2011: This patient was vaccinated with MENVEO (batch number M10030) on 28 Feb 2011. The patient was administered only the MenA lyophilized conjugate component of MENVEO, which was reconstituted with sterile solvent. The patient did not receive MenCYW-135 liquid conjugate component of MENVEO. No adverse event had occurred.
a couple of days after the shot, I started getting muscle pain, a fever and chills that would come & go and headache with nausea. On april 8th, after lunch I had to lay down on the floor because I thought I was going to pass out. After about ten minutes & breaking out in a sweat, I was ok.On saturday the 10th, I sat down for supper & could only eat a few bites before I thought I was going to throw up.
Narrative: Headache, Myalgia, FATIGUE, SINUS PRESSURE
1st dose of Moderna given to pediatric patient; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of Moderna given to pediatric patient) in a 9-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2022, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of Moderna given to pediatric patient). On 06-Jan-2022, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (1st dose of Moderna given to pediatric patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. It was reported pediatric patient received the 1st dose of Moderna vaccine.
Nighttime Fever ~78 hours after injection, Tired/Lock of Appetite/Nausea next morning, some minor vomiting; Pedialytes popsicle administered
fatigue, lack of energy, low back pain, neck stiffness, tingling sensation in lt extremities, tightness in chest, soreness of lt arm (site of inject), lightheadedness; (arm soreness @ inject site only on initial day given;
Presented 12NOV w/hive like blotches to arms, trunk & lower extremities that itched; Seen that day @ clinic given DPH; ON 14NOV went to ER; also exp swollen hands;
Experienced nasal congestion afterwards. Put on Augmentin. Finished course, now erosive rash on skin and in mouth.
Trouble breathing and then swelling of my tongue. (Anaphylaxis)  Next day - scratchy throat, sore arm where I received shot and headache.
A report was received from a health care professional on 16Oct02, concerning a 6 month old male vaccinee who was inadvertently administered 0.25ml IM into the vastus lateralis on the 16Oct02. On 16Oct02, the infant suffered a medication error by receiving 0.25ml Fluvirin into the vastus lateralis. The infant had not experienced any adverse events at the time of the report but was being closely monitored. There was insufficient information to determine the reporter's causality assessment. PJP200200609, PJP200200671, PJP200200670, PJP200200668, PJP200200667, PJP200200666, PJP200200665, PJP200200664, PJP200200662, PJP200200663.
Pt recv vax on 3/24/98; 2-3 min post vax pt exp convulsive seizure,  pt confused 5-10 min
There was an administration error. The Pharmacist gave the injection which was unusually painful. When she applied the  bandaid, the pressure caused liquid to be expelled ( blood or vaccine.  She jumped, made an audible sound of surprise, then wiped the dripping substance that was running down my arm.  Within an hour the area around the injection site was extremely sore.  The next morning when I removed the bandaid, there were multiple (3?) small blood spots on it.  But, concerning, some clear  liquid seemed to have run through them leaving some streaking!  None of the customary tiredness on the 2nd or 3rd day following the booster.   I am certain I did not get a full dose.  I need to determine if I should repeat!
Red and itchy. Spotchy skin limited to upper back bilaterally  At 17:08 BP 122/84 HR 82 O2Sat 98  Skin Signs: Rash and hives  At 17:33 BP 122/84 HR 75 O2Sat 98 Vitals taken at 17:08. Continued monitoring. 17:15 rash noticeably improved.  Disposition: Home by Self
Large red lesion developed at injection site measuring 2?x2? that was extremely warm to touch, painful, and itchy.  This occurred 8 days after receiving injection. Symptoms remained for approximately 4 days.
Feels week all over; Coughing; Sweating at night; Though it was a flu bug; Trouble all night sleeping; Blotches in both arms; Joint pain; Feeling achy/Muscle aches; Nausea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Feels week all over), COUGH (Coughing), HYPERHIDROSIS (Sweating at night), INFLUENZA (Though it was a flu bug) and INSOMNIA (Trouble all night sleeping) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced ASTHENIA (Feels week all over), COUGH (Coughing), HYPERHIDROSIS (Sweating at night), INFLUENZA (Though it was a flu bug), INSOMNIA (Trouble all night sleeping), PAPULE (Blotches in both arms), ARTHRALGIA (Joint pain), MYALGIA (Feeling achy/Muscle aches), NAUSEA (Nausea) and PYREXIA (Fever). At the time of the report, ASTHENIA (Feels week all over), COUGH (Coughing), HYPERHIDROSIS (Sweating at night), INFLUENZA (Though it was a flu bug), INSOMNIA (Trouble all night sleeping), PAPULE (Blotches in both arms), ARTHRALGIA (Joint pain), MYALGIA (Feeling achy/Muscle aches), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown.            No concomitant medication was reported.  Treatment medication was not provided by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.
Patient received dose 3 in series too early. No reported adverse reaction to receiving this dose too early.  Dose 1--3/1/17 Dose 2--6/14/17 Dose 3--due 8/9/17, given 7/21/17.
At 3:50 pm 2-1-16 patient called Dr. office to report left arm painful and stiff, body shaking, blood sugar 175. Took TYLENOL. Patient was instructed to relax, apply a warm towel to the area and move the arm. If tingling, numbness or condition worsens go to the emergency room. Patient arrived at emergency room 2-1-2016 at 19:32 with complaint of fever and left arm pain. Patient said initial Pneumovax 23 injection site had immediate pain "like a shock" down the patient left arm. Fever onset this afternoon. Fever continues tonight as well as pain. Temp 101.7 oral, pulse 106 radial, resp 20, bp 161/74 right arm sitting, O2sat 94. IV started 1955 NS 0.9% at 50ml/hr. Vancomycin started 2105. Lab results: 2-1-16 WBC 16.93 BUN 24, Neutrophil % 88.9, Neutrophil count 15.04.  2-2-16 labs: WBC 18.59, BUN 23, Neutrophil % 85, Neutrophil count 15.81.  2-3-16 labs: WBC 11.71, BUN 21, neutrophil % 79.6, neutrophil count 9.32. Patient receive physical therapy while in hospital.
metallic flavor in the mouth; fever; chills; Joint pain; pain in the injection site; felt unwell; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt unwell), DYSGEUSIA (metallic flavor in the mouth), PYREXIA (fever), CHILLS (chills) and ARTHRALGIA (Joint pain) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 940915) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Sputnik (2nd dose) and Sputnik (1st dose). Past adverse reactions to the above products included No adverse event with Sputnik and Sputnik.    On 24-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced MALAISE (felt unwell) and VACCINATION SITE PAIN (pain in the injection site). On 24-Jan-2022, the patient experienced DYSGEUSIA (metallic flavor in the mouth), PYREXIA (fever), CHILLS (chills) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. In January 2022, DYSGEUSIA (metallic flavor in the mouth), CHILLS (chills) and ARTHRALGIA (Joint pain) had resolved. On 30-Jan-2022, VACCINATION SITE PAIN (pain in the injection site) had resolved. At the time of the report, MALAISE (felt unwell) and PYREXIA (fever) outcome was unknown.            At the evening of the day of vaccination he had fever, chills, joint pain, metallic flavor in the mouth. Those symptoms lasted one day. He took Paracetamol to treat those symptoms. During the next day he felt unwell and he had fever again. He took Ibuprofen to treat those symptoms. He also had pain in the injection site, that lasted until the day of reporting.  No concomitant medications were reported.
Mother called 8/13/08 late am said patient awoke today 8/13/08 with T-100.2 and hive rash with itching. No dyspnea. Instructed take Benadryl, Tylenol or Advil - call doctor. If problems breathing go to ER. I called mom 8/14/08 am patient took Benadryl this am rash - hives gone, no fever; itching better. Mother to call if any problems or patient not better.
FELT AWFUL; FELT LETHARGIC; DRY HEAVES; FEVER OF 102.1; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced felt awful. On 08-APR-2021, the subject experienced felt lethargic. On 08-APR-2021, the subject experienced dry heaves. On 08-APR-2021, the subject experienced fever of 102.1. Laboratory data included: Body temperature (NR: not provided) 102.1 (unit not provided). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt awful, felt lethargic, dry heaves, and fever of 102.1 on APR-2021. This report was non-serious.
This spontaneous prospective pregnancy report was received from a female patient of unknown age, reporting on herself. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL 9 for prophylaxis (strength, dose, frequency, route of administration, lot number and expiration date were not reported). On an unknown date, after receiving the GARDASIL 9 vaccine, the patient discovered that she was pregnant. The patient's last menstrual period, due date and estimated date of conception were not provided.
Report 2001021434-1 describes cellulitis at the injection site of a five year old male who received Infanrix. Medical history included redness and swelling at the injection site and a fever following receipt of an injection of Acel-Imune on 06/28/2001. These events required unspecified treatment in the ER. Concurrent conditions and medications were not specified. On 08/14/2001, the child received an injection of Infanrix. The reporter indicated that the child had received previous injections of Infanrix, but the number of previous injections was not provided. On 08/14/2001, an unspecified time post-immunization, the child experienced redness and swelling at the injection site, and fever. On 08/16/2001, he was seen by the physician, who made a diagnosis of cellulitis and prescribed Keflex 250mg twice daily and Benadryl every four or five hours, as needed. The cellulitis resolved on an unspecified date. The reporter considered the cellulitis to be moderate in intensity and related to Infanrix administration.
Flushing/sweating, dizziness. BP 92/57 (pulse 70). Final BP 109/71 (pulse 76), O2 sat 100%.
dizzy; feel like im slightly drunk; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and FEELING DRUNK (feel like im slightly drunk) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy) and FEELING DRUNK (feel like im slightly drunk). At the time of the report, DIZZINESS (dizzy) and FEELING DRUNK (feel like im slightly drunk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information was provided.   Reporter did not allow further contact
I did not feel well. I was lethargic and achy immediately following the vaccination. On Tuesday I got the chills and woke up sweaty. I've had multiple episodes of waking up with chills and sweaty.
Extreme fatigue from 10AM, April 17 through April 18 and continuing presently.  Slept most of the time.
Redness and swelling to right upper arm. No pain or fever. Treated with Benadryl, Motrin, and heat/cold.
Admission history and physical for 8/28/03, sates that pt had a well-baby's visit on August and at which time he received his 1 year old shots. Presented today in the pediatric clinic with an increase cough and a four day history of 30-35 varicella lesions. The lesions on the trunk are crusted. Dx'ed varicella and probable varicella pneumonia.
Vaccine expired on 5/17/19 and was administered on 6/5/19.
Immediately after receiving my vaccine, I didn't notice much more than a sore arm at injection site. I did have a fever that night. The highest it got was around 102. I was taking Tylenol to treat that. When I woke up Sunday morning, I had a rash on my forehead more on the left than right side. The rash got progressively worse and spread to other places. I called my doctor Monday morning who was booked up, so I texted pictures of the rash on my face. From the photos, she was able to diagnose Shingles. She prescribed Valtrex. My face is still covered in a rash but I have not been running a fever anymore.
First time ever to receive a flu shot. Onset of sxs the evening of vaccination with sore throat, cough, chills, fever. Had shortness of breath on 11/18 with body aches. etc
Vaccine administration error: Patient received second dose of Moderna vaccine early. First dose was administered on 03/02/21 and patient received second dose on 03/20/21.
Patients sister contacted the pharmacy the day after the vaccine to inform us that this was his third COVID vaccine.  She stated he received 2 other shots at facility.  We are unaware of any adverse events.
Nauseous; Dizzy; Tingling, numbness on my left side; Numbness on my left side; Sores on my face / Painful/Tingling Blemishes on Left side of face; Sores on my face / Painful/Tingling Blemishes on Left side of face; Sores on my face / Painful/Tingling Blemishes on Left side of face; Low grade fever; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 62-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th August 2020, the patient received the 1st dose of Shingrix. In August 2020, 10 min after receiving Shingrix, the patient experienced nausea, dizziness, tingling, numbness, skin ulcer, skin disorder, facial pain and low grade fever. In 2020, the outcome of the nausea and dizziness were recovered/resolved and the outcome of the tingling, numbness, skin ulcer, skin disorder, facial pain and low grade fever were not recovered/not resolved.   It was unknown if the reporter considered the nausea, dizziness, tingling, numbness, skin ulcer, skin disorder, facial pain and low grade fever to be related to Shingrix.  Additional information was received as follows: The patient received the first dose of Shingrix on 6th August 2020 and about 10 minutes after injection, the patient felt nauseous and dizzy. Last few days, the patient had tingling, low grade fever, left sided numbness on the left side and was breaking out with sores on face and new onset of painful/tingling blemishes on left side of face. The patient questioned whether the patient was getting Shingles.
Information has been received from a consumer concerning her 6 month old son who on 26-OCT-2006 was vaccinated with an oral first dose of rotavirus reassortant vaccine live (human bovine). It was reported that no adverse experiences was observed. No product quality complaint was involved. No other information was provided. Additional information is not expected.